N. Fujii

发表

Unique Monoclonal Antibody Recognizing the Third Extracellular Loop of CXCR4 Induces Lymphocyte Agglutination and Enhances Human Immunodeficiency Virus Type 1-Mediated Syncytium Formation and Productive Infection

E. Baba, Yuetsu Tanaka, Tohru Kimura, 2001, Journal of Virology.

[Enterohemorrhagic Escherichia coli O157 outbreak in Obihiro-city--biological and molecular characteristics among O157 isolates].

T. Shirahata, K. Takeshi, S. Makino, 1997, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Bactericidal Activities of Rat Defensins and Synthetic Rabbit Defensins on Staphylococci, Klebsiella pneumoniae (Chedid, 277, and 8N3), Pseudomonas aeruginosa (Mucoid and Nonmucoid Strains), Salmonella typhimurium (Ra, Rc, Rd, and Re of LPS Mutants) and Escherichia coli

T. Moriya, K. Amako, O. Kohashi, 1992, Microbiology and immunology.

Elevated Serum Levels of Stromal-Derived Factor-1A Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients

L. To, T. Lapidot, Sally K. Martin, 2005 .

Inhibitory Mechanism of the CXCR4 Antagonist T22 against Human Immunodeficiency Virus Type 1 Infection

J. Hoxie, S. Minoguchi, Yuetsu Tanaka, 1999, Journal of Virology.

T134, a Small-Molecule CXCR4 Inhibitor, Has No Cross-Drug Resistance with AMD3100, a CXCR4 Antagonist with a Different Structure

M. Baba, H. Tamamura, M. Premanathan, 1999, Journal of Virology.

The earliest stages of B cell development require a chemokine stromal cell-derived factor/pre-B cell growth-stimulating factor.

N. Fujii, T. Kishimoto, H. Kawamoto, 2001, Immunity.

Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140.

M. Matsuoka, A. Otaka, H. Tamamura, 2001, Bioorganic & medicinal chemistry letters.

Structural studies on the chondroitinase ABC-resistant sulfated tetrasaccharides isolated from various chondroitin sulfate isomers.

N. Fujii, M. Masuda, K. Sugahara, 1994, Carbohydrate research.

Synthesis and evaluation of bifunctional anti-HIV agents based on specific CXCR4 antagonists-AZT conjugation.

A. Otaka, H. Tamamura, H. Nakashima, 2001, Bioorganic & medicinal chemistry.

A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance.

D. Kohda, A. Otaka, H. Tamamura, 1993, Biochimica et biophysica acta.

Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion

N. Fujii, Y. Koyanagi, H. Nakashima, 1992, Antimicrobial Agents and Chemotherapy.

Analysis of the interaction of an anti-HIV peptide, T22 ([Tyr5, 12, Lys7]-polyphemusin II), with gp120 and CD4 by surface plasmon resonance.

A. Otaka, H. Tamamura, M. Waki, 1996, Biochimica et biophysica acta.

Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection.

A. Otaka, H. Tamamura, R. Arakaki, 1998, Bioorganic & medicinal chemistry.

Downsizing of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II), with the maintenance of anti-HIV activity and solution structure.

A. Otaka, H. Tamamura, H. Nakashima, 1998, Bioorganic & medicinal chemistry.

Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II).

A. Otaka, H. Tamamura, R. Arakaki, 1998, Bioorganic & medicinal chemistry.

An anti-HIV peptide, T22, forms a highly active complex with Zn(II).

A. Otaka, H. Tamamura, M. Waki, 1996, Biochemical and biophysical research communications.

Binding of tachyplesin I to DNA revealed by footprinting analysis: significant contribution of secondary structure to DNA binding and implication for biological action.

Y. Sugiura, Y Sugiura, A Yonezawa, 1992, Biochemistry.

CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment

J. Juarez, S. Fricker, L. Bendall, 2007, Leukemia.

Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria.

N. Fujii, K. Miyajima, K. Matsuzaki, 1997, Biochimica et biophysica acta.

Fine structure of a virus-encoded helper T-cell epitope expressed on FBL-3 tumor cells

H. Uenishi, H. Tamamura, H. Yamagishi, 1994, Journal of virology.

CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model

P. Opolon, F. Pasquier, E. Solary, 2012, Cell Death and Disease.